|Year : 2007 | Volume
| Issue : 3 | Page : 209-213
Immune responsiveness associated with experimental Encephalitozoon intestinalis infection in immunocompetent rats
ICJ Omalu1, DD Duhlinska1, GI Anyanwu1, VA Pam2, PU Inyama1
1 Department of Biological Sciences Federal University of Technology Minna, Nigeria
2 National Veterinary Research Institute Jos, Nigeria
|Date of Submission||16-Dec-2005|
|Date of Acceptance||10-Feb-2007|
Department of Biological Sciences Federal University of Technology Minna
Source of Support: None, Conflict of Interest: None
Purpose: Microsporidial infections have been recognized as an increasingly important infection in immuncompromised patients, particularly those infected with HIV/AIDS. This study was designed to study immune responses associated with experimental Encephalitozoon intestinalis infection in immunocompetent rats. Materials and Methods: Thirty-four Rats in 3 groups, A (Control), B (Intraperitoneal) and C (Oral) were given injections of 0.5 ml of 2 x 10 6 of purified spores of Encephalitotozoon intestinalis spores and were observed for serum specific IgG for 21 days using both direct and indirect ELISA. Results: In indirect ELISA, specific lgG were detected on days 7, 14 and 21 for the group B rats and on day 21 for group C and in direct ELISA method, specific lgG were detected in-group B rats on days 7 and 21, for group C rats on day 21 only, while in the control rats, specific lgG were not detected. There was no significant difference between the direct and indirect methods (df=1, X 2 , P>0.05). E. intestinalis was observed in stool samples of rats in 1/12 (08.33%) on days 14 and 21 in group B, and in 4/10 (33.33%), 3/10 (25.00%) and 2/10 (16.67%) on days 7, 14 and 21 respectively in group C. In group A, which is the control rats, no microsporidia were observed on days 0, 7, 14 and 21. Conclusions: There were no changes in the T-lymphocyte counts of rats prior to and after inoculation with spores. Extensive lesions were observed along the intestinal walls especially on the middle and lower sections of group C rats only.
Keywords: Microsporidia, Encephalitozoon intestinalis, ELISA. T-Lymphocytes
|How to cite this article:|
Omalu I, Duhlinska D D, Anyanwu G I, Pam V A, Inyama P U. Immune responsiveness associated with experimental Encephalitozoon intestinalis infection in immunocompetent rats. Indian J Med Microbiol 2007;25:209-13
|How to cite this URL:|
Omalu I, Duhlinska D D, Anyanwu G I, Pam V A, Inyama P U. Immune responsiveness associated with experimental Encephalitozoon intestinalis infection in immunocompetent rats. Indian J Med Microbiol [serial online] 2007 [cited 2019 Mar 26];25:209-13. Available from: http://www.ijmm.org/text.asp?2007/25/3/209/34760
Microsporidia have long been recognized in many invertebrate and vertebrate species. They have been regarded as organisms of low pathogenicity in most mammalian species, causing spontaneous natural disease only under unusual circumstances. In mammals, three basic types of host/parasite responses have been described: a) A hypersensitive immune response reported in very young carnivores, b) A latent or clinically undetectable infection seen in euthymic mice and rabbits and, c) Clinical disease due to parasite proliferation in immuno suppressed animals and athymic mice. 
Immune responses are designed to recognize and eliminate foreign agents including microorganisms. The immune systems of mammals have evolved the ability to generate responses that are acquired, specific and anamnestic so that the microorganisms are eliminated more efficiently after second and subsequent exposures. Immune responses expressed in mammals principally involve the interactions of leukocytes, which are regulated by B and T lymphocytes. The time required for specific serum antibodies to be expressed after experimental inoculations of Encephalitozoon cuniculi into euthymic mice or rabbits is affected by the route of infection. Microsporidia - specific antibodies were first detected in the sera of rabbits and mice approximately 7-10 days after parenteral inoculations (intravenous, intraperitoneal, subcutaneous or intracerebral) and were not detected until approximately 21 days after oral inoculation. Immunoglobulin M (lgM) responses occurred first and then declined as the lgG responses increased. The lgG levels in serum tended to peak about four to six weeks after parenteral inoculation and usually remained high (> 800 as measured by ELISA) for the life of the host. , The expression of antibody responses in immunologically immature animals infected with microsporidia generally was delayed but these animals eventually achieved the same levels of specific serum lgG expression as observed in animals infected as adults. 
Mice infected with E. cuniculi remained chronically infected and continued to express specific serum antibodies, whereas mice inoculated with killed E. cuniculi only transiently expressed specific antibodies.  Mice inoculated with viable E. intestinalis organisms cleared their infections and also transiently expressed antibodies, whereas IFN-γ receptor knocked out mice, which did become chronically infected and survived experimental E. intestinalis infections, did continue to express antibodies.  This study shows the detection of serum specific IgG and other immune responses to E. intestinalis.
| ~ Materials and Methods|| |
Encephalitozoon intestinalis were obtained from stool, washed by repeated centrifugation and purified by density gradient centrifugation with percoll  and stored in phosphate buffered saline (PBS) at 4o C for use in coating the plates for enzyme-linked immunosorbent assay (ELISA)
Experimental animals and organism
Six to ten week old male and female rats were used in the study. Three groups of 12 rats per cage were provided food and water and housed in a micro-insulator environment. Rats were purchased from the University of Jos, animal farm.
Inoculation and monitoring of infections
Twelve rats (group B) were given intraperitoneal (IP) injections of 0.5 mL volumes of 2 × 10 6 E. intestinalis spores, 12 rats (group C) were given 0.5 mL volumes of 2 × 10 6 of E. intestinalis spores orally and the other 10 rats (group A) served as control.
Sera were obtained on days 0, 7, 14 and 21 and assayed by both direct and indirect ELISA for specific IgG antibodies to E. intestinalis .
Stool analysis and CD4 + cell count for rats
Stool specimens were analysed on days 0, 7, 14 and 21 for the presence of Microsporidia by modified Giemsa staining technique. 
CD4 + cells were counted using the Cyflow machine on days 0 and 21 only.
Direct and indirect ELISA
To measure the relative levels of E. intestinalis serum specific antibodies a modified and indirect ELISA method , was employed. For direct ELISA, E. intestinalis spores was adjusted to 2 x 10 6 /mL in PBS as antigens and 100 µL was added to each of 96-micro ELISA plate and Incubated with 100 µL/well of lgG (whole molecule) peroxidase conjugate (Sigma product. No. A4416) containing bovine serum albumin (BSA: 3%w/v) with O-phenylenediamine dihydrochloride (OPD) 0.4 mg/mL in 0.05 M phosphate citrate buffer, pH 5.0 containing 0.03% sodium probate. ELISA plates were read at 405 nm. ELISA readings greater than the positive control from calculation were declared positive.
Examination of intestinal mucosae for lesion
Three sections of the intestinal mucosa such as upper, middle and lower, were processed and examined for lesions. All rats infected intraperitoneally and orally as well as controls were examined. 
| ~ Results|| |
Stool samples of rats
In group A (control rats), no microsporidia were observed on days 0, 7, 14 and 21 when their stool samples were examined. For group B, which were given intraperitoneal injections, E. intestinalis was observed in 1(08.33%) of the 12 rats on days 14 and 21, while in the 10 rats in group C, E. intestinalis occurred in 4(33.33%), 3(25.00%) and 2(16.67%) on days 7, 14 and 21 respectively [Table - 1]. There was no significant difference (χ2 , P > 0.05) in the number of spores shed by the rats inoculated with spores and those by the control group.
CD4 + cells/mL of rats
There were no changes in the T-lymphocytes counts of rats prior to and after inoculation with spores. The mean CD4 + cells/mL of rats remained 90 cells/mL except for group C that had 89 cells/mL on day 21. There were no significant differences (χ2 , P > 0.05) in the cell counts before and after inoculation with spores of E. intestinalis in the three groups [Table - 2].
Serum-specific IgG of rats
Prior to inoculation, rats were screened for antibodies against intestinal microsporidia spores by both the direct and the indirect ELISA, with E. intestinalis spores as antigens. Pre-inoculation sera and healthy-rats-control sera did not react with any of the parasite spores. Rats were also screened for serum parasite specific antibody response 7-21 days post inoculation.
For the indirect ELISA, specific lgG was detected on days 7, 14 and 21 for the group B with rats given intraperitoneal injections. In group C with rats given oral inoculation, specific lgG were detected on day 21, while none was detected in the control rats [Figure - 1]
In the direct ELISA method, specific lgG to E. intestinalis were detected in-group B rats on days 7 and 21. For group C rats lgG was detected on day 21 only, while in the control rats, specific lgG were not detected [Figure - 2]. There were no significant differences between the direct and indirect method (df=1, χ2 , P>0.05) in the detection of serum specific lgG.
Tissue examination of small intestinal mucosae
Encephalitozoon intestinalis were not detected in the tissues of rats from groups A, B and C, however, rats in group C given oral inoculation had focal to extensive lesions along the intestinal walls especially on the middle and lower sections. Lesions were predominantly characterized by scattered miliary necroses and granulomas.  Diffuse or focal lesions in the intestinal wall consist of inflammatory oedema with numerous macrophages. Rats in group B given intraperitoneal injections and group A (controls) showed no lesions along the intestinal mucosa.
| ~ Discussion|| |
Microsporidia are common parasites of laboratory animals and recently are being recognized more frequently in humans, particularly in AIDS patients. As such, information gleaned from natural and experimental infections of laboratory animals provides a basis for understanding the host-parasite relationship of microsporidiosis in humans.
The usefulness of an animal model depends upon similarities with the human disease. Such comparisons are difficult at present because relatively little is known about the pathogenesis and clinical spectrum of disease in humans infected with microsporidia. To date, Encephalitozoon and Nosema are commonly reported in laboratory animals and insects and are only recently being reported with greater frequency in humans. Information from experimental microsporidial infections of mice and rats should increase our understanding of the pathogenesis and clinical course of microsporidiosis in humans. Microsporidiosis in mice and monkeys appears to parallel what we do know about human microsporidiosis. 
Since there is no in vitro culture system presently available, it has been impossible to produce enough antigens to screen for specific antibodies. This problem was circumvented by developing a procedure for the isolation, purification and sterilization of parasite spores from human stools. Apparently, the best preservation of the spore antigens is obtained when using gentle filtration, centrifugation in isotonic conditions and gradual addition of low concentrations of antibodies to the final faecal suspensions.
Healthy rats given E. intestinalis by intraperitonal and oral inoculations displayed no clinical signs of disease and only sporadically shed spores in stools, which conforms to an earlier report on E. cuniculi and E. hellem on healthy monkeys.  Monkeys given oral inoculation with microsporidia, which were immunocompetent at the time of microsporidia inoculation, still maintained a normal peripheral blood CD4 + /CD29 + T lymphocyte levels (15-30%) and the clinical signs of immunodeficiency were absent. In the present study, the CD4 + T lymphocytes remained same prior to and after inoculation.  This intact immune system was able to keep the parasites in check and prevented clinical disease though there were sub-clinical signs, which were detected at necropsy, which included inflammatory lesions occurring along the walls of the intestine. They also observed lesions in the pancreas, lung and spleen of athymic mice and ascites was common as well. These tissue sites of infection parallel several reports of microsporidiosis due to Encephalitozoon - associated hepatitis, peritonitis, sinusitis and nephritis which are usually observed in immunodeficient patients. ,,
Encephalitozoon is a microsporidia parasite that has a wide range of hosts including rodents, lagomorphs, carnivores and primates.  Experimental E. cuniculi infections in immunocompetent hosts produced only chronic asymptomatic brain and kidney lesions, in contrast to the inoculation of immunodeficiency animals such as athymic mice, resulting in lethal disease. ,
The animals in this study expressed relatively high levels of specific antibodies, especially in the rats infected intraperitoneally, than those inoculated orally, which was earlier observed. , Numerous inoculation routes have been used for establishing systemic microsporidial infections in laboratory animals, including intravenous, intranasal oral, intraperitoneal, intrarectal and intracerebral inoculations, although the lengths of time required for inducing systemic infections and the pathogenicity for these routes varied.  Because autopsies are rarely permitted in immunodeficient patients, it is difficult to fully appreciate the clinical spectrum of Encephalitozoon - associated microsporidiosis and to ascertain which route of infection for microsporidiosis primarily occurs in immuno compromised patients.
The rat model used in this study has some advantages. The study has established Encephalitozoon infections in rats by both intraperitoneal and oral inoculations. The animals have expressed high antibody levels to microsporidia and parasites have been demonstrated in stools. Additional studies are required in evaluating diagnostic and chemotherapeutic methods in context of progressing immunodeficiency. Presently, antibodies are considered diagnostic for microsporidiosis in immunocompetent animals and parasite detection is required for diagnosing microsporidiosis in immunodeficient individuals. Additional studies are needed for comparing intravenous, intrapeitoneal and oral inoculations in immunocompetent rats and mice with different species of microsporidia. Although it is believed that most natural infections in human occur by ingestion of organisms, inhalation has been reported as a likely route of infection  and trauma may lead to infection.
Several studies using immunodeficient animals have described features similar to the infections observed in immunodeficient human patients. The disseminated lesions and tissue sites of infection that developed in SCID mice were similar to lesions that were reported in AIDS patients with Encephalitozoon infections. Athymic mice as a model to study host parasite interactions during E. cuniculi infections have been used. The liver and spleen were two preferential sites of infection and mean survival time of athymic mice inoculated intraperitoneally was three weeks. ,, Microsporidiosis in immunodeficient animals will provide a useful model for studies of the microsporidial pathogenesis, mechanisms of resistance, immunotherapy and in evaluating potential antimicrosporidial agents.
This present study using healthy rats was particularly important for demonstrating that resistance to lethal disease is dependent on a functioning immune system which is consistent with the increased reports of disease associated with microsporidiosis in AIDS patients and other immunodeficient patients.
| ~ Acknowlegement|| |
We wish to express our profound gratitude to Mr. Raphael of University of Jos Animal Farm for his assistance.
| ~ References|| |
|1.||Didier ES. Immunology of Microsporidiosis. Contri Microbiol 2000;6:193-208. |
|2.||Didier ES, Bessinger GT. Host-parasite relationships in microsporidiosis: Animal models and immunology. The microsporidia and microsporidiosis. Washington Am Soc Microbiol 1999;30:225-57. |
|3.||Schmidt EC, Shadduck JA. Murine encephalitozoonosis model for studying the host-parasite relationship of a chronic infection. Infect Immunol 1983;40:936-42. |
|4.||Lyngset A. A survey of serum antibodies to Encephalitozoon cuniculi in breeding rabbits and their young. Lab Anim Scien 1980;30:558-61. |
|5.||Liu JJ, Shadduck JA. Encephalitozoon cuniculi infection in MRL/MPJ-LPR (lymphoproliferation) mice. Lab Anim Sci 1988;38:685-8. [PUBMED] |
|6.||El Fakhry Y, Achbarou A, Desportes-livage, I, Mazier D. Encephalitozoon cuniculi humoral responses in interferon-gamma receptor knockout mice infected with a microsporidium pathogenic in AIDS patients. Experiment Parasi 1998;89:113-1. |
|7.||Accoceberry I, Thellier M, Desportes-Livage I, Achbarou A, Biligui S, Danis M, et al. Production of monoclonal antibodies directed against the microsporidium. Enterocytozoon bieneusi. J Clin Microbiol 1999;37:4107 -12. |
|8.|| Van-Gool T, Hollister WS, Eeftinck-Schattenkerk J, Van-Den Bergh Weerman MA, Terpstra WJ, Vanketel RJ, et al . Diagnosis of Enterocytozoon bieneusi Microsporidiosis in AIDS patients by recovery of spores from faces. Lancet 1990;336:697-8. |
|9.||Didier ES, Varner PW, Didier PJ, Aldras AM, MIllichamp NJ, Murphey-Corb M, et al . Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys. Folia Parasitol 1994;41:1-11. [PUBMED] |
|10.||Hollister WS, Canning EU. An enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Encephalitozoon cuniculi and its use in determination of infections in man. Parasitol 1987;94: 209-19. |
|11.|| Lillie RD, Harold M, Fullmer DD. Histopathologic Technic and Practical Histochemistry. 4 th ed. McGraw Hill Book Company, A Blakiston Publication: 1976. p. 1055. |
|12.||Koudela B, Vitovec J, Kucerova Z, Ditrich O, Travnicek J. The severe combined immunodeficiency mouse as a Model for Encephalitozoon cuniculi Microsporidiosis. Folia Parasitologica 1993;40:279-86. |
|13.||Terada S, Reddy KR, Jeffers LJ, Cali A, Schiff ER. Microsporidian hepatitis in the Acquired Immunodefiency Syndrome. Ann Intern Med 1987;107:61-2. |
|14.||Zender HO, Arrigoni E, Eckert J, Kapanci Y. A case of Encephalitozoon cuniculi peritonitis in a patient with AIDS. Am J Clin Pathol 1989;92:252-6. |
|15.||Metcalfe T, Doran R, Rowland P, Curry A, Lacey CJ. Microsporidial Keratoconjunctivitis in a British patient with AIDS. Br J Ophthamol 1992;76:177-8. |
|16.||Canning EU, Lom J. The Microsporidia of Vertebrates. 2 nd ed. Academic Press: London; 1986. p. 289. |
|17.||Ganon J. A survey of Encephalitozoon cuniculi in laboratory animal colonies in the United Kingdom. Lab Anim 1980;14:91-4. |
|18.||Schwartz DA, Bryan RT, Hewan-Lowe KO, Visvesvara GS, Weber R, Cali A, et al . Diseminated Microsporidiosis ( Encephalitozoon hellem ) in biopsies, smears and intact globes from seven AIDS patients. Am J Ophthamol 1992;115:285-92. |
|19.|| Schmidt EC, Shadduck JA. Mechanisms of resistance to the intracellular Encephatilozoon cuniculi: In mice . J Immunol 1984;133:2712-9. |
[Figure - 1], [Figure - 2]
[Table - 1], [Table - 2]
|This article has been cited by|
||Evaluation of the co-agglutination test in diagnosis of experimental microsporidiosis
| ||Maha R. Gaafar |
| ||Experimental Parasitology. 2011; 128(1): 18 |
|[VIEW] | [DOI]|